CorMedix, Inc.

Contributing Author

Recent Articles by CorMedix, Inc.

Oct-31	CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025 CRMD GlobeNewswire
Oct-23	CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath CRMD GlobeNewswire
Oct-20	CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance CRMD GlobeNewswire
Sep-29	CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO CRMD GlobeNewswire
Sep-08	CorMedix Announces Strategic Minority Investment in Talphera CRMD GlobeNewswire
Sep-02	CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team CRMD GlobeNewswire
Aug-28	CorMedix to Participate in Upcoming Investor Conferences CRMD GlobeNewswire
Aug-07	Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update CRMD GlobeNewswire
Aug-07	CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings CRMD GlobeNewswire
Jun-27	CorMedix Inc. Announces Pricing of Public Offering of Common Stock CRMD GlobeNewswire
Jun-26	CorMedix Inc. Announces Proposed Public Offering of Common Stock CRMD GlobeNewswire
Jun-23	CorMedix inc. Announces Customer Implementation CRMD GlobeNewswire
May-30	CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference CRMD GlobeNewswire
May-15	CorMedix Inc. to Participate in the RBC Global Healthcare Conference CRMD GlobeNewswire
May-06	CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update CRMD GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.